Search results
Author(s):
Rahul Sakhuja
,
James L Januzzi
Added:
3 years ago
Introduction
With nearly 500,000 new cases per year and direct costs estimated as high as US$38 billion annually, congestive heart failure (CHF) has become a major priority in modern medicine. This crisis will continue to grow as the population ages, thus the discernment of new diagnostic and therapeutic strategies to improve prognosis and reduce costs is critical.1
The irony is that therapies…
View more
Author(s):
Robert F Riley
,
James M McCabe
Added:
3 years ago
Heart disease remains the leading cause of death in the US, with ischemic heart disease comprising almost half of these deaths based on the most recent 2013 mortality data.1 While there have been reports of declining rates of acute myocardial infarction (AMI) from various registries and Medicare beneficiary reports, coronary heart disease remained the underlying cause of death in one out of seven…
View more
Author(s):
Peter H Jones
Added:
3 years ago
High Residual Cardiovascular Risk in Diabetic Patients Treated with Statins
According to the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII), diabetes is a coronary heart disease (CHD) risk equivalent.1 One major factor contributing to the excess risk of cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (T2DM) is atherogenic dyslipidemia,…
View more
Treating the Common Dyslipidemia in Patients with Type 2 Diabetes—The Effects of Fenofibrate on…
Author(s):
Sergio Fazio
Added:
3 years ago
Article
Author(s):
Myung H Park
Added:
3 years ago
Author(s):
James A Reiffel
Added:
3 years ago
Atrial fibrillation (AF) is the most common sustained, medically significant, and troublesome arrhythmia encountered in clinical practice. AF has been associated with decreased quality of life (symptoms), serious morbidity (thromboemboli and tachycardia-induced cardiomyopathy), and increased risk of mortality. Several articles1,2 have reviewed this arrthymia in depth including its presentations,…
View more
Author(s):
Kusha Rahgozar
,
Sharon Bruoha
,
Edwin C Ho
,
et al
Added:
2 years ago
Author(s):
Sergio Fazio
Added:
3 years ago
Current Indications for Statin and Fibrate Therapy
The evidence of cardiovascular protection afforded by statins has recently extended beyond patients with hypercholesterolemia. With the publication of several trials,1-7 bold extrapolations of the power of statin therapy in cardiovascular prevention have been offered:
statins equally reduce risk in subjects with or without…
View more
Single-Ventricle Physiology
Author(s):
Lydia Taranto
,
Tabitha Moe
Added:
3 years ago
Article
Author(s):
Victor L Serebruany
Added:
3 years ago
Understanding of the pathogenesis of congestive heart failure (CHF) has improved remarkably in recent years. However, despite better knowledge and novel pharmaceutical strategies, this disease is still one of the most brutal killers in the Western world. The pathophysiology of CHF is complex, and much of our comprehension revolves strictly around the neurohormonal and mechanical mechanisms…
View more